As-needed budesonide–formoterol as good as ICS maintenance in mild asthma
For mild asthma, as-needed budesonide–formoterol (ICS-LABA*) significantly reduces the short-term risk of severe exacerbations, even with just a single day of increased use, compared with as needed SABA** — and this protective benefit appears as good as that seen with regular use of maintenance ICS, suggests a post hoc analysis of the SYGMA*** 1 study.
